Skip to main navigation Skip to search Skip to main content

Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial

  • Mary B. Leonard
  • , Justine Shults
  • , Jin Long
  • , Robert N. Baldassano
  • , J. Keenan Brown
  • , Kevin Hommel
  • , Babette S. Zemel
  • , Soroosh Mahboubi
  • , Krista Howard Whitehead
  • , Rita Herskovitz
  • , Dale Lee
  • , Joseph Rausch
  • , Clinton T. Rubin
  • Stanford University
  • University of Pennsylvania
  • Mindways Software, Inc.
  • University of Washington
  • University of Cincinnati

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Pediatric Crohn's Disease (CD) is associated with low trabecular bone mineral density (BMD), cortical area, and muscle mass. Low-magnitude mechanical stimulation (LMMS) may be anabolic. We conducted a 12-month randomized double-blind placebo-controlled trial of 10 minutes daily exposure to LMMS (30 Hz frequency, 0.3 g peak-to-peak acceleration). The primary outcomes were tibia trabecular BMD and cortical area by peripheral quantitative CT (pQCT) and vertebral trabecular BMD by QCT; additional outcomes included dual-energy X-ray absorptiometry (DXA) whole body, hip and spine BMD, and leg lean mass. Results were expressed as sex-specific Z-scores relative to age. CD participants, ages 8 to 21 years with tibia trabecular BMD <25th percentile for age, were eligible and received daily cholecalciferol (800 IU) and calcium (1000 mg). In total, 138 enrolled (48% male), and 121 (61 active, 60 placebo) completed the 12-month trial. Median adherence measured with an electronic monitor was 79% and did not differ between arms. By intention-to-treat analysis, LMMS had no significant effect on pQCT or DXA outcomes. The mean change in spine QCT trabecular BMD Z-score was +0.22 in the active arm and -0.02 in the placebo arm (difference in change 0.24 [95% CI 0.04, 0.44]; p = 0.02). Among those with >50% adherence, the effect was 0.38 (95% CI 0.17, 0.58, p < 0.0005). Within the active arm, each 10% greater adherence was associated with a 0.06 (95% CI 0.01, 1.17, p = 0.03) greater increase in spine QCT BMD Z-score. Treatment response did not vary according to baseline body mass index (BMI) Z-score, pubertal status, CD severity, or concurrent glucocorticoid or biologic medications. In all participants combined, height, pQCT trabecular BMD, and cortical area and DXA outcomes improved significantly. In conclusion, LMMS was associated with increases in vertebral trabecular BMD by QCT; however, no effects were observed at DXA or pQCT sites.

Original languageEnglish
Pages (from-to)1177-1188
Number of pages12
JournalJournal of Bone and Mineral Research
Volume31
Issue number6
DOIs
StatePublished - Jun 1 2016

Keywords

  • ANABOLICS
  • BONE QCT
  • CLINICAL TRIALS
  • DXA
  • SKELETAL MUSCLE

Fingerprint

Dive into the research topics of 'Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial'. Together they form a unique fingerprint.

Cite this